CA2244907A1 - Formulated product - Google Patents

Formulated product

Info

Publication number
CA2244907A1
CA2244907A1 CA002244907A CA2244907A CA2244907A1 CA 2244907 A1 CA2244907 A1 CA 2244907A1 CA 002244907 A CA002244907 A CA 002244907A CA 2244907 A CA2244907 A CA 2244907A CA 2244907 A1 CA2244907 A1 CA 2244907A1
Authority
CA
Canada
Prior art keywords
formulated product
molecule
discordance
metabolite
adequate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002244907A
Other languages
French (fr)
Other versions
CA2244907C (en
Inventor
Laszlo Vojcek
Tibor Bedo
Tibor Pok
Gabor Bartok
Zsolt Agni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceutical Works PLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU9603631A external-priority patent/HU225149B1/en
Application filed by Individual filed Critical Individual
Publication of CA2244907A1 publication Critical patent/CA2244907A1/en
Application granted granted Critical
Publication of CA2244907C publication Critical patent/CA2244907C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to the use of a molecule having the general formula:
CA002244907A 1996-12-30 1997-12-30 Formulated product Expired - Fee Related CA2244907C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HUP9603631 1996-12-30
HU9603631A HU225149B1 (en) 1996-12-30 1996-12-30 Use of dobesilate salts for the manufacture of medicaments for the treatment or prevention of embryonic retardation or discordance
PCT/HU1997/000090 WO1998029103A2 (en) 1996-12-30 1997-12-30 Use of calcium dobesilate for the manufacture of a medicament for the treatment of embryonic retardation

Publications (2)

Publication Number Publication Date
CA2244907A1 true CA2244907A1 (en) 1998-07-09
CA2244907C CA2244907C (en) 2005-12-06

Family

ID=89994598

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002244907A Expired - Fee Related CA2244907C (en) 1996-12-30 1997-12-30 Formulated product

Country Status (1)

Country Link
CA (1) CA2244907C (en)

Also Published As

Publication number Publication date
CA2244907C (en) 2005-12-06

Similar Documents

Publication Publication Date Title
CA2169145A1 (en) Substituted benzisoxazole and benzisothiazole herbicidal agents
CA2264116A1 (en) Process for preparing intermediates to florfenicol
CA2103838A1 (en) Novel 7-(substituted)-8-(substituted-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
AU679457B2 (en) File compression processor
EP1586558A3 (en) Bis-sulfonamide hydroxyethylamino retroviral protease inhinitors
CA2348742A1 (en) Carbocyclic potassium channel inhibitors
CA2430470A1 (en) Novel use of a peptide class of compound for treating allodynia or other different types of chronic or phantom pain
CA2085555A1 (en) Dual inhibitors of no synthase and cyclooxygenase, process for their preparation and therapeutical compositions containing them
CA2173418A1 (en) Benzonitriles and benzofluorides
AU3284395A (en) Synthesis of 1,1,1,3,3,-pentafluoropropane
RU93058618A (en) Pyrazolopyrimidine and pyrimidinylbisphosphonic esters used as anti-inflammatory drugs
AU7556994A (en) Methods for the diagnosis of alzheimer's disease
AU8824691A (en) Stable solid acetyl peroxyborate compounds
AU6752990A (en) Combatting slime-forming microorganisms
CA2028514A1 (en) Treatment of depression
CA2244907A1 (en) Formulated product
CA2035499A1 (en) Substituted triazolopyridazines
AU6939696A (en) Substituted benzoic or thiobenzoic acid anilides as fungicides
CA2083361A1 (en) Fish production
CA2100637A1 (en) Process for the production of 2-substituted-5-chlorimidazole-4-carbaldehydes
AU6301094A (en) The use of compositions for combating tumour diseases
BR9909029A (en) Stabilization of organic polyisocyanates
EP0897903A3 (en) Ketone-derivatives of indene, dihydronaphthalene or naphthalene compounds for the treatment of hyperlipidemia
WO1998029103A3 (en) Use of calcium dobesilate for the manufacture of a medicament for the treatment of embryonic retardation
CA2118565A1 (en) Process for the preparation of 3.beta.-aminocholanic acid derivatives

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed